TMDX — TransMedics Group Inc · P/E 17, rev $363.9M

TransMedics Group Inc (TMDX) is a medical devices company listed on NASDAQ.

Latest reported TMDX revenue for 2026-06-30 was $363.9M. Net income was $22.0M. TMDX currently screens at market cap $2.53B and trailing P/E 16.8.

Use this TMDX page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the TMDX quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the TMDX SEC filings page. Lician reads the product cache first so this HTML stays unique to TransMedics Group Inc even when a live quote feed is slow.

TransMedics Group Inc latest statements (FY2025)

Latest cached year on this hub. Full TMDX income, balance, and cash tables.

  • Revenue$605.5M
  • Net Income$190.3M
  • Total Assets$1.07B
  • Total Debt$0
  • Free Cash Flow$133.6M

TMDX recent filings